RxDoctor Payments Data

Kimberly Selwood, DO

Family Medicine · Vineland, NJNPI 1255969234

Payments from drug & device makers

$1,728in general payments, 2019–2025

Across 111 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$487
  • Pfizer$216
  • AstraZeneca$179
  • Novo Nordisk$172
  • Astellas Pharma US Inc$166
  • Lilly USA, LLC$126
  • plus $382 from 11 others

What the payments were for

  • Food & beverage$1,728100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,728 in reported general payments places this provider in the 75th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$45,232
Medicare patients
129
Services billed
367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$89,199
MounjaroTirzepatide36$44,508
FarxigaDapagliflozin Propanediol27$33,141
EliquisApixaban34$27,751
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$23,856
TrulicityDulaglutide18$20,595
JanuviaSitagliptin Phosphate13$16,909
XareltoRivaroxaban15$10,412
MyrbetriqMirabegron14$9,262
Rosuvastatin Calcium172$4,169
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$3,353
Aripiprazole11$2,421
Albuterol Sulfate HfaAlbuterol Sulfate89$2,155
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide44$2,152
Losartan Potassium154$2,082

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$172$89,19970 claims
Lilly USA, LLCMounjaro, Trulicity$126$65,10354 claims
AstraZenecaFarxiga$179$33,14127 claims
PfizerEliquis$216$27,75134 claims
GSKTrelegy Ellipta$47$23,85634 claims
Astellas Pharma US IncMyrbetriq$166$9,26214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,084 family medicine providers in New Jersey.

Other family medicine in Vineland

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →